{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Determinar el perfil de morbilidad, uso de servicios, costes y medicamentos recomendados, en pacientes que demandan asistencia por trastorno de ansiedad generalizada (TAG) en atenci\u00f3n primaria (AP).",
        "Estudio retrospectivo y multic\u00e9ntrico.",
        "Cinco centros de AP urbanos, gestionados por Badalona Serveis Assistencials, S.A.",
        "Pacientes mayores de 18 a\u00f1os atendidos durante el a\u00f1o 2006. Se form\u00f3 un grupo de referencia/poblacional con el resto de pacientes. Los pacientes con TAG se clasificaron en 4 grupos seg\u00fan el uso de f\u00e1rmacos.",
        "Generales, casu\u00edstica/comorbilidad, utilizaci\u00f3n de recursos sanitarios y costes ambulatorios (visitas, procedimientos diagn\u00f3sticos/terap\u00e9uticos y f\u00e1rmacos). Se contabiliz\u00f3 la incapacidad laboral como coste indirecto, y los f\u00e1rmacos recomendados seg\u00fan la evidencia disponible. An\u00e1lisis multivariado: regresi\u00f3n log\u00edstica, modelos de ANCOVA y de componentes principales para la correcci\u00f3n del modelo (p < 0,05).",
        "De 65.767 pacientes incluidos, el 4,6% (intervalo de confianza [IC] del 95%, 3,9-5,3) presentaron TAG. La presencia de \u00e9ste tuvo una relaci\u00f3n independiente en mujeres (<i>odds ratio</i> [OR] = 1,8), dislipemia (OR = 1,2), tabaquismo (OR = 1,4), s\u00edndrome depresivo (OR = 1,2) e ictus (OR = 1,6) (p < 0,02). El coste directo medio/anual corregido por edad, sexo y carga de morbilidad fue de 685 frente a 557 \u20ac (p < 0,001). Todas las categor\u00edas de costes directos fueron mayores en el TAG. El uso de tratamiento recomendado fue del 40,1% (IC del 95%, 38,4-41,8).",
        "Los pacientes que demandaron atenci\u00f3n por TAG presentan un elevado n\u00famero de comorbilidades y costes directos asociados en el \u00e1mbito de la AP de salud. Desde este \u00e1mbito deber\u00edan establecerse medidas encaminadas a mejorar el abordaje terap\u00e9utico de estos pacientes."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19100147",
  "DateCompleted": {
    "Year": "2009",
    "Month": "05",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "spa"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0212-6567",
      "JournalIssue": {
        "Volume": "40",
        "Issue": "12",
        "PubDate": {
          "Year": "2008",
          "Month": "Dec"
        }
      },
      "Title": "Atencion primaria",
      "ISOAbbreviation": "Aten Primaria"
    },
    "ArticleTitle": "[Influence of morbidity and the use of health resources in patients who require care for generalised anxiety disorder in the primary health care setting].",
    "Pagination": {
      "StartPage": "603",
      "EndPage": "610",
      "MedlinePgn": "603-10"
    },
    "Abstract": {
      "AbstractText": [
        "To evaluate the co-morbidity, health care use, economical impact, and availability of effective treatments used in generalised anxiety disorder (GAD) patients in a primary care setting (PCS).",
        "A retrospective multicentre population-based study.",
        "Five primary care clinics managed by Badalona Serveis Assistencials S.A., Barcelona, Spain.",
        "Outpatient records of patients over 18 years managed at 5 PCSs during 2006. Patients with and without GAD were compared. In GAD patients, 4 groups were established for comparison, according to pharmacological prescription.",
        "Main outcomes measures were general, reason/co-morbidity, health care use and primary care cost (visits, diagnostic/therapeutic tests, and drugs). We counted work absenteeism as an indirect cost. Pharmacological prescription was studied according to evidence-based recommendations and Spanish health-approved indications. The statistical analysis included a multivariate model: logistic regression, analysis of covariance (ANCOVA), P< .05. RESULTS. Of the 65 767 patients included, 4.6% (95% confidence interval [CI], 3.9-5.3) had GAD. Patients with/without GAD, the average episode/year was 6.1 versus 4.7 and attendance/year 10.0 versus 7.6; P< .001. GAD was associated with women (odds ratio [OR], 1.8), dyslipidemia (OR, 1.2), smoking (OR, 1.4), depression (OR, 1.2), and cerebrovascular accident (OR, 1.6) (P< .02). The mean direct cost/year adjusted by age, gender and morbidity load was euro686 versus euro557 (P< .001). GAD was associated with higher directs costs. The recommended treatment was followed in 40.1% of total patients (95% CI, 38.4-41.8).",
        "Patients with GAD have greater co-morbidity and higher direct costs in PCS. Means designed to improve the recognition and treatment of these patients should be established in the PCS."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Direcci\u00f3n de Planificaci\u00f3n. Badalona Serveis Assistencials, S.A. Badalona. Barcelona. Espa\u00f1a. asicras@bsa.cat"
          }
        ],
        "LastName": "Sicras-Mainar",
        "ForeName": "Antoni",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Blanca-Tamayo",
        "ForeName": "Milagrosa",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Navarro-Artieda",
        "ForeName": "Ruth",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pizarro-Paixa",
        "ForeName": "Israel",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "G\u00f3mez-Lus Centelles",
        "ForeName": "Susana",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Multicenter Study"
    ],
    "VernacularTitle": "Influencia de la morbilidad y uso de recursos en pacientes que demandan atenci\u00f3n por trastorno de ansiedad generalizada en el \u00e1mbito de la atenci\u00f3n primaria de salud."
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "Aten Primaria",
    "NlmUniqueID": "9111075",
    "ISSNLinking": "0212-6567"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "economics",
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Costs and Cost Analysis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Health Services"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Primary Health Care"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Spain"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}